The Impact of PCSK9 Inhibitors on Circulatory Inflammation

JACC Asia · Published 2026-08-01 · DOI 10.1016/j.jacasi.2026.05.033

Free full text

Authors (8)

Deng Bing-yan, Wang Jing-ya, Yuan Yu-juan, Dong Xiang-yu, Lai Hong-mei, Peng Hui, Yang Yi-ning, Yu Xiao-lin

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Bing-yan, D., Jing-ya, W., Yu-juan, Y., et al. (2026). The Impact of PCSK9 Inhibitors on Circulatory Inflammation. JACC Asia. https://doi.org/10.1016/j.jacasi.2026.05.033

Related articles

• Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study · Cardiology and Therapy · 2025 · Cites or is cited by this article
• Endovenous Radiofrequency Ablation for Varicose Veins · JACC Asia · 2026 · Same journal
• Prognostic Value of Persistent Microvascular Obstruction on Follow-Up Cardiac MRI After Reperfused STEMI · JACC Asia · 2026 · Same journal
• Smartphone-Based Remote Monitoring for Cardiac Implantable Electronic Devices · JACC Asia · 2026 · Same journal
• Clinical Outcomes of Drug-Coated Balloon Following Directional Coronary Atherectomy in Acute vs Chronic Coronary Syndrome · JACC Asia · 2026 · Same journal
• Angiography-Derived Index of Microcirculatory Resistance Predicts Microvascular Obstruction and Infarct Size in Patients With STEMI · JACC Asia · 2026 · Same journal
• Diagnosing Transthyretin Cardiac Amyloidosis in Japan · JACC Asia · 2026 · Same journal
• Trends in Cardiovascular Diseases Burden in China, 1990-2023 · JACC Asia · 2026 · Same journal
• Straining During Defecation or Gut Environment · JACC Asia · 2026 · Same journal
• Post-TAVR Conduction Disturbances · JACC Asia · 2026 · Same journal